REICHLING STEVEN 4
4 · Accelerate Diagnostics, Inc · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2023-02-13+9,439→ 81,641 total - Sale
Common Stock
2023-02-13$0.60/sh−4,823$2,894→ 76,818 total - Award
Employee Restricted Stock Units
2023-02-13+123,600→ 123,600 total→ Common Stock (123,600 underlying) - Exercise/Conversion
Employee Restricted Stock Units
2023-02-13−9,439→ 0 total→ Common Stock (9,439 underlying)
Footnotes (5)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 113,265 restricted stock units, which vests in equal amounts every month for 12 months.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The reporting person received restricted stock units on February 13, 2023, which will vest on March 8, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
- [F5]Not Applicable.